NATURAL VANASPATI
Natural Vanaspati Share Price
Natural Vanaspati Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Natural Vanaspati Investment Rating
-
Master Rating:
-
Natural Capsules has an operating revenue of Rs. 135.07 Cr. on a trailing 12-month basis. An annual revenue growth of 70% is outstanding, Pre-tax margin of 14% is healthy, ROE of 16% is good. The company has a reasonable debt to equity of 39%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 32% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Oper Rev Qtr Cr
- Operating Expenses Qtr Cr
- Operating Profit Qtr Cr
- Depreciation Qtr Cr
- Interest Qtr Cr
- Tax Qtr Cr
- Net Profit Qtr Cr
Natural Vanaspati Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 50 Day
- 100 Day
- 200 Day
- 20 Day
- 50 Day
- 100 Day
- 200 Day
Natural Vanaspati Resistance and Support
Natural Vanaspati Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- Week
- 1 Month
- 6 Month
Natural Vanaspati Result Highlights
Natural Vanaspati Synopsis
BSE-Medical-Diversified
Natural Capsules is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 135.07 Cr. and Equity Capital is Rs. 7.01 Cr. for the Year ended 31/03/2022. Natural Capsules Ltd. is a Public Limited Listed company incorporated on 20/09/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014742 and registration number is 014742.- Market Cap
- 383
- Sales
- 135
- Shares in Float
- 0.33
- No of funds
- 1
- Yield
- 0.2
- Book Value
- 4.18
- U/D Vol ratio
- 1.1
- LTDebt / Equity
- 16
- Alpha
- 0.54
- Beta
- 0.79
Natural Vanaspati
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 56.57%
- 56.57%
- 56.58%
- Individual Investors
- 33.38%
- 32.1%
- 30.54%
- Others
- 10.05%
- 11.33%
- 12.88%
Natural Vanaspati Management
- Name
- Designation
- Mr. C P Rangachar
- Chairman & Ind.Director
- Mr. Sunil Laxminarayan Mundra
- Managing Director
- Mr. Laxminarayan Moondra
- Whole Time Director
- Mr. Satyanarayan Mundra
- Whole Time Director
- Mr. Sushil Kumar Mundra
- Director
- Mrs. Jyothi Mundra
- Director
- Mr. Anjan K Roy
- Independent Director
- Mr. Pramod Kasat
- Independent Director
Natural Vanaspati Forecast
Price Estimates
Natural Vanaspati FAQs
What is Share Price of Natural Vanaspati ?
Natural Vanaspati share price is ₹00 As on 11 August, 2022 | 08:20
What is the Market Cap of Natural Vanaspati ?
The Market Cap of Natural Vanaspati is ₹ Cr As on 11 August, 2022 | 08:20
What is the P/E ratio of Natural Vanaspati ?
The P/E ratio of Natural Vanaspati is As on 11 August, 2022 | 08:20
What is the PB ratio of Natural Vanaspati ?
The PB ratio of Natural Vanaspati is As on 11 August, 2022 | 08:20